News

The event provided an excellent opportunity to meet current and potential partners, explore new business opportunities and discuss future collaborations across international markets.

As Cor.Con. International continues to expand its international footprint, face-to-face meetings remain an important part of our approach to building strong, long-term partnerships and developing new opportunities in the healthcare sector.

Epilamba Junior by Cor.Con. International has been shortlisted as a finalist for the CPHI Pharma Awards 2026 in the Finished Formulation category.

Cor.Con. International had the pleasure of contributing to a lecture at the University of Parma entitled “From Idea to Market: How to Develop a Food Supplement.”

We believe that interaction between industry, universities, and local institutions plays an essential role in helping students bridge the gap between academic knowledge and real-world applications.

Cor.Con. International continues its innovation pathway in 2026 In 2026, Cor.Con. International further strengthened its commitment toward innovation and business development through participation in dedicated funded initiatives. Grants & Funded initiatives obtained in 2026 The company obtained support through the BANDO PI 25 initiative promoted by CCIAA. The project contributed to the enhancement of innovation […]

In 2026 we have increased the number of events we will attend to better understand your requirements, develop innovative ideas, and translate unmet needs into innovative and scientifically grounded products.

We are pleased to visit for the first time Riyadh to attend the new CPhI Middle-East Riyadh from 11 to 13 May 2026 at Hall 1 booth W90 with our portfolio of innovative food supplements. A 3-day event that will take place in person with interactive online features.

Cor.Con. International announces the publication of new clinical data in the peer-reviewed journal Global Pediatric, reporting on the adjunctive use of the nutraceutical formulation Epilamba® in pediatric patients affected by epilepsy.

Hearing disorders are becoming increasingly common. According to recent data, more than 59 million people in Europe report hearing issues.

Acustop is a game-changer product. Our innovative supplement is rationally formulated and clinically tested to support the inner ear structures and functions.

We are pleased to come back to Frankfurt after 3 years to attend the new CPhI Worldwide Frankfurt from 28th to 30th October 2025 at Hall 3.1 booth A56 with our portfolio of innovative food supplements. A 3-day event that will take place in person with interactive online features.

Cor.Con. International will be joining for the first time PharmaSynergyOTC that will take place on the 24th – 25th of September in Rome, Italy. PharmaSynergyOTC brings together the Business Development and Distribution community through pre-arranged one-on-one partnering meetings, with a focus on products in OTC, Nutraceuticals, and Cosmeceuticals.

Cor.Con. International is more committed than ever to forging strategic partnerships that shape the future of wellness, and we are excited to share what is next!

This year, our team is actively participating in both digital and in-person international events, continuing to build a strong global presence.

Meeting our partners in person has been truly rewarding, allowing us to discuss the challenges and opportunities of the Emirates market in depth and to strategically plan our next steps in the region. These face-to-face interactions are essential for strengthening relationships and working together towards driving innovation in healthcare.

The Emilia-Romagna Chambers of Commerce and the Emilia-Romagna Region approved our projects for increasing our international presence in the market of food supplements, cosmeceuticals and functional food through the grants “Digital Export 2023” and “Digital Export 2024-25”. These grants aim at strengthening the ability of regional companies to operate in international markets by assisting them in identifying new business opportunities in existing markets and in seeking new outlets, thus helping to increase the competitiveness of the Emilia-Romagna production system.

Cor.Con. International advances innovation and export development in 2025 In 2025, Cor.Con. International continued its pathway of international growth and innovation through the participation in strategic funded initiatives. Grants & Funded initiatives obtained in 2025 The company obtained support through the Bando Digital Export 24 25 initiative promoted by ER and CCIAA. The project contributed […]

The discovery of the first pediatric epilepsy supplement developed in Italy is a significant step forward. We discuss it in our article!

Epilamba was rationally formulated and clinically tested with the help of experts to address the unmet need to address the side effects and comorbidities associated with antiepileptic drug therapy.

Cor.Con. International will attend CPhI MIlano from 8th to 10th October 2024 at Hall 10 booth 10D48 with our portfolio of innovative food supplements and services at your disposal. A 3-day event that will take place in person with interactive online features.

“Emilia-Romagna Region” and the European Community approved our project for increasing our international presence in the market of food supplements, cosmeceuticals and functional food through the grant “Support to Internationalization Projects for SMEs 2023-24”. This grant aims at supporting SMEs from the Emilia-Romagna region in overcoming the pandemic crisis and in strengthening their resiliency through the export increase and the scale up of exporting companies that operate both in presence and through the digital platforms.

Arab Health 2024 has been a thrilling four days of sharing and learning. It is now time to head back home, have some rest and enhance our future goals with this new knowledge. We had the pleasure to meet and host at our booth more than 70 companies during four very busy days.

Cor.Con. International strengthens digital export and internationalization activities in 2024 In 2024, Cor.Con. International continued its strategic investment in international development and digital export activities through the participation in several funded initiatives. Grants & Funded initiatives obtained in 2024 The company obtained support through the Bando Digital Export 2023 initiative promoted by CCIAA. The project […]